Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study
Nicola Sgherza(University of Bari Aldo Moro), Pellegrino Musto(University of Bari Aldo Moro), Enrica Antonia Martino(Ospedale Annunziata di Cosenza), Daniela Roccotelli(Casa Sollievo della Sofferenza), Candida Germano, Olga Battisti, Giuseppe Mele(Italian Society of Physiotherapy), Maria Teresa Petrucci(Policlinico Umberto I), Roberta Della Pepa(University of Naples Federico II), Fabrizio Pane(Federico II University Hospital), Salvatore Palmieri(Ospedale Antonio Cardarelli), Anna Mele, Paola Curci(University of Bari Aldo Moro), Francesca Fazio(Sapienza University of Rome), Daniele Derudas(Centro di Riferimento Oncologico), Domenico Pastore(Istituto di Ematologia di Bologna), Francesco Di Raimondo(University of Catania), Bernardo Rossini(Istituto Tumori Bari), Giulia Palazzo(Azienda Ospedaliera S.Giuseppe Moscati), Emanuela Resta(Sapienza University of Rome), Simona Rasola(University of Bari Aldo Moro), Concetta Conticello(University of Catania)
Cited by 2
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
|PubMed|2006|909
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study
|Haematologica|2009|309